Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
915071-41-9 | 1-(3-Chloro-4-fluorophenyl)biguanide HCl | AA00IGNP | MFCD00126332
918789-44-3 | 3,4-Dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic acid | AA00IGUH | MFCD11848179
923789-06-4 | 4-(2-Furylmethyl)-5-morpholin-4-yl-4h-1,2,4-triazole-3-thiol | AA00IH1D | MFCD08691140
926248-67-1 | 3-(4-Bromopyrazol-1-yl)benzoic acid | AA00IH6Z | MFCD09042625
93-62-9 | N-(2-Hydroxyethyl)iminodiacetic acid | AA00IHDB | MFCD00004293
933823-89-3 | 5,6-Difluoroquinazolin-4(3h)-one | AA00IHIP | MFCD24564974
937601-91-7 | Methyl 4-(2-(4-benzylpiperazin-1-yl)ethoxy)benzoate | AA00IHQ0 | MFCD08689770
942-56-3 | 2,2-Dimethyl-3,4-dihydro-2h-1-benzopyran-5-ol | AA00IHVV | MFCD10698827
944709-71-1 | 2-(N,N-Dimethylamino)-3-formyl-4-iodopyridine | AA00II48 | MFCD09702016
946-02-1 | 4-Chlorobutyl benzoate | AA00IIB1 | MFCD00019005